1
Total investments
0
Early stage
1
Mid stage
0
Late stage
10y
Years active
Portfolio
1 investments Β· sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Nov 2016
Midaxo's Complete M&A Software Solution helps teams review 5x more deals, react to opportunities faster, focus on high-priority deals, and track pipeline progress against growth targets. Manage everything in one platform, instead of stitching together separate CRMs, VDRs, reporting tools, spreadsheets, & task trackers. Learn more about our end-to-end M&A platform on our website.
Experience Β· 5 entries
All (5)
Investments (1)
Founder (1)
Board (1)
2016
Board Member
Nov 2016
Midaxo's Complete M&A Software Solution helps teams review 5x more deals, react to opportunities faster, focus on high-priority deals, and track pipeline progress against growth targets. Manage everything in one platform, instead of stitching together separate CRMs, VDRs, reporting tools, spreadsheets, & task trackers. Learn more about our end-to-end M&A platform on our website.
2015
S
Stella EOC Capital
Managing Partner
Jan 2015
2013
S
Springside AB
Managing Director
Mar 2013
2000
Co Founder and CEO
Jan 2000
Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.
Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen).
1995
A
Aros Securities
Equity Analyst
1995